Identification and validation of LDHA and SLC16A1 for predicting prognosis and diagnosis in lower-grade glioma
LDHA and SLC16A1 have potential prognostic and diagnostic values for LGG. Therefore, SLC16A1 may serve as a potential biomarker for the diagnosis and treatment of LGG.
Authors
- X. Huang (ORCID: https://orcid.org/0000-0002-9388-6909)
- Jingyi Huang (ORCID: https://orcid.org/0000-0001-5590-8954)
- Qiuxuan Wang
- Wen Wang (ORCID: https://orcid.org/0000-0003-4788-4459)
- Jiao Liu (ORCID: https://orcid.org/0000-0003-0304-241X)
- Zhijun Li (ORCID: https://orcid.org/0000-0002-3909-488X)
Institutions
- Weifang Medical University (CN)
- Shandong Jiaotong University (CN)
- Linyi City Chinese Medicine Hospital (CN)
- Shandong Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1007/s12672-025-03297-2
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63